Long noncoding RNAs (lncRNAs) are emerging as crucial contributors to the development of hepatocellular carcinoma (HCC) and are involved in the stemness regulation of liver cancer stem cells (LCSCs). However, cancer cell stemness-associated lncRNAs and their relevance in prediction of clinical prognosis remain largely unexplored. In this study, through the transcriptome-wide screen, we identified a total of 136 LCSC-associated lncRNAs. We evaluated the prognostic value of these lncRNAs and optimally established an 11-lncRNA (including AC008622.2, AC015908.3, AC020915.2, AC025176.1, AC026356.2, AC099850.3, CYTOR, DDX11-AS1, HTR2A-AS1, LINC02870, and SNHG3) prognostic risk model. Multivariate analysis revealed that the risk score is an independent prognostic predictor for HCC patients, which outperforms the traditional clinical pathological factors. Gene set enrichment analysis suggested that the high-risk score reflects the alteration of pathways involved in cell cycle, oxidative phosphorylation, and metabolism. Furthermore, functional studies on SNHG12, the leading candidate of the risk lncRNAs, revealed that knockdown of SNHG12 reduces the abilities of HCC cells stemness, proliferation, migration, and invasion. In summary, we constructed a prognostic risk model based on 11 LCSC-associated lncRNAs, which might be a promising prognostic predictor for HCC patients and highlight the involvement of lncRNAs in LCSC-associated treatment strategy in clinical practice.
Get full access to this article
View all access options for this article.
References
1.
BeyesS., AndrieuxG., SchremppM., AicherD., WenzelJ., Antón-GarcíaP., et al. (2019). Genome-wide mapping of DNA-binding sites identifies stemness-related genes as directly repressed targets of SNAIL1 in colorectal cancer cells. Oncogene, 38, 6647–6661.
2.
BlackA.P., and MehtaA.S. (2018). The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome. Curr Opin Pharmacol, 41, 74–78.
3.
BlancheP., DartiguesJ.F., and Jacqmin-GaddaH. (2013). Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med, 32, 5381–5397.
4.
CaoP., JinQ., FengL., LiH., QinG., and ZhouG. (2020). Emerging roles and potential clinical applications of noncoding RNAs in hepatocellular carcinoma. Semin Cancer Biol, 12, S1044-579X(20)30191-7.
5.
DingS., QuW., JiaoY., ZhangJ., ZhangC., and DangS. (2018). LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway. Cancer Biomark, 22, 217–226.
6.
DuchartreY., KimYM., and KahnM. (2016). The Wnt signaling pathway in cancer. Crit Rev Oncol Hematol, 99, 141–149.
7.
EpsteinJI., EgevadL., AminMB., DelahuntB., SrigleyJR., HumphreyPA., et al. (2016). The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol, 40, 244–252
8.
FDA-NIH Biomarker Working Group. (2016). BEST (Biomarkers, EndpointS, and other Tools) Resource. Available at: www.ncbi.nlm. nih.gov/books/NBK338448. Accessed January10, 2018.
9.
FriedmanJ., HastieT., and TibshiraniR. (2010). Regularization paths for generalized linear models via coordinate descent. J Stat Softw, 33, 1–22.
10.
GaoJ., DaiC., YuX., YinX.B., and ZhouF. (2020). Long noncoding RNA LINC00324 exerts protumorigenic effects on liver cancer stem cells by upregulating fas ligand via PU box binding protein. FASEB J, 34, 5800–5817.
11.
GuanZ., ChengW., HuangD., and WeiA. (2018). High MYBL2 expression and transcription regulatory activity is associated with poor overall survival in patients with hepatocellular carcinoma. Curr Res Transl Med, 66, 27–32.
12.
GuoJ.C., YangY.J., ZhengJ.F., ZhangJ.Q., GuoM., YangX., et al. (2019). Silencing of long noncoding RNA HOXA11-AS inhibits the Wnt signaling pathway via the upregulation of HOXA11 and thereby inhibits the proliferation, invasion, and self-renewal of hepatocellular carcinoma stem cells. Exp Mol Med, 51, 1–20.
13.
HänzelmannS., CasteloR., and GuinneyJ. (2013). GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14,7.
14.
HeB., PengF., LiW., and JiangY. (2019). Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling. J Cell Biochem, 120, 2908–2918.
15.
JemalA., BrayF., CenterMM., FerlayJ., WardE., and FormanD. (2011). Global cancer statistics. CA Cancer J Clin, 61, 69–90.
16.
KhadirnaikarS., ChatterjeeA., KumarP., and ShuklaS. (2020). A greedy algorithm-based stem cell lncRNA signature identifies a novel subgroup of lung adenocarcinoma patients with poor prognosis. Front Oncol 10,1203.
17.
LiT., JinX., DongJ., and DengH. (2020). Long noncoding RNA ARSR is associated with a poor prognosis in patients with colorectal cancer. J Gene Med 22,e3241.
18.
LiaoX., ZhuG., HuangR., YangC., WangX., HuangK., et al. (2018). Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma. Cancer Manag Res, 10, 787–803.
19.
LigatG., SchusterC., and BaumertT.F. (2019). Hepatitis B virus core variants, liver fibrosis, and hepatocellular carcinoma. Hepatology, 69, 5–8.
20.
LouJ., ZhangL., LvS., ZhangC., and JiangS. (2017). Biomarkers for hepatocellular carcinoma. Biomark Cancer, 9, 1–9.
21.
LuG.M., RongY.X., LiangZ.J., HunagD.L., MaY.F., LuoZ.Z., et al. (2020). Multiomics global landscape of stemness-related gene clusters in adipose-derived mesenchymal stem cells. Stem Cell Res Ther 11,310.
22.
PanX., GuoZ., ChenY., ZhengS., PengM., YangY., et al. (2020). STAT3-induced lncRNA SNHG17 exerts oncogenic effects on ovarian cancer through regulating CDK6. Mol Ther Nucleic Acids, 22, 38–49.
23.
Sanchez-AlvarezR., Martinez-OutschoornU.E., LinZ., LambR., HulitJ., HowellA., et al. (2013). Ethanol exposure induces the cancer-associated fibroblast phenotype and lethal tumor metabolism: implications for breast cancer prevention. Cell Cycle, 12, 289–301.
24.
ShanY., MaJ., PanY., HuJ., LiuB., and JiaL. (2018). LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1. Cell Death Dis 9,722.
25.
SongJ., WuX., MaR., MiaoL., XiongL., and ZhaoW. (2019). Long noncoding RNA SNHG12 promotes cell proliferation and activates Wnt/β-catenin signaling in prostate cancer through sponging microRNA-195. J Cell Biochem, 120, 13066–13075.
26.
SteyerbergE.W., and VergouweY. (2014). Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J, 35, 1925–1931.
27.
SubramanianA., TamayoP., MoothaV.K., MukherjeeS., EbertB.L., GilletteM.A., et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A, 102, 15545–15550.
28.
SunL., WangL., ChenT., ShiY., YaoB., LiuZ., et al. (2020). LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells. Cell Death Dis 11,95.
29.
TangR., WuJ.C., ZhengL.M., LiZ.R., ZhouK.L., ZhangZ.S., et al. (2018). Long noncoding RNA RUSC1-AS-N indicates poor prognosis and increases cell viability in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci, 22, 388–396.
30.
TsengH.S., ChenL.S., KuoS.J., ChenS.T., WangY.F., and ChenD.R. (2014). Tumor characteristics of breast cancer in predicting axillary lymph node metastasis. Med Sci Monit, 20, 1155–1161.
31.
VillanuevaA. (2019). Hepatocellular Carcinoma. N Engl J Med, 380, 1450–1462.
32.
VitaleI., ManicG., De MariaR., KroemerG., and GalluzziL. (2017). DNA damage in stem cells. Mol Cell, 66, 306–319.
33.
WangJ.H., WangC.C., HungC.H., ChenC.L., and LuS.N. (2012). Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol, 56, 412–418.
34.
WangY., HeL., DuY., ZhuP., HuangG., LuoJ., et al. (2015). The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell, 16, 413–425.
35.
WeiL., WangX., LvL., LiuJ., XingH., SongY., et al. (2019). The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma. Mol Cancer 18,147.
36.
WuD., HeX., WangW., HuX., WangK., and WangM. (2020). Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1. Mol Oncol, 14, 2332–2351.
37.
XuM., ChenX., LinK., ZengK., LiuX., XuX., et al. (2019). lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a/b and miR-214 in colorectal cancer. J Hematol Oncol 12,3.
38.
XuanY., and WangY. (2019). Long non-coding RNA SNHG3 promotes progression of gastric cancer by regulating neighboring MED18 gene methylation. Cell Death Dis 10,694.
39.
YangH., JiangZ., WangS., ZhaoY., SongX., XiaoY., et al. (2019). Long non-coding small nucleolar RNA host genes in digestive cancers. Cancer Med, 8, 7693–7704.
40.
ZhaoX., ZhengF., LiY, HaoJ., TangZ., TianC., et al. (2019). BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits. Redox Biol, 20, 427–441.
41.
ZhuP., WangY., WuJ., HuangG., LiuB., YeB., et al. (2016). LncBRM initiates YAP1 signalling activation to drive self-renewal of liver cancer stem cells. Nat Commun 7,13608.
42.
ZhuQ., YangH., ChengP., and HanQ. (2019). Bioinformatic analysis of the prognostic value of the lncRNAs encoding snoRNAs in hepatocellular carcinoma. Biofactors, 45, 244–252.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
